Netscientific Share Discussion Threads

[escapetohome] 07/6/2021 07:51

How things change.

[escapetohome] 07/6/2021 07:51

And at one stage they were going to delist this company , it was hard to get funding.

It couldn’t be more different now.

[blakieboy7] 07/6/2021 07:47

Very blue Monday!!

[samsung2020] 07/6/2021 07:36

Brilliant RNS. Surely, NSCI will blast over £1 with this news!

[blakieboy7] 07/6/2021 07:32

Speaking about the agreement, Dr David Ribeiro, CEO of ProAxsis , commented:"We're excited to be involved with this assay to support such a key area of global healthcare need. The research team at AstraZeneca have already completed significant optimisation and validation work, which has demonstrated the assay's high potential sensitivity and specificity of detecting SARS-CoV-2 antibodies. ProAxsis will extend this work to support the identification of people who have raised antibodies against this challenging virus."John Clarkson, Chairman of Netscientific plc and ProAxsis , added: "Expanding the product portfolio and customer service offering are stated goals for ProAxsis, so we're delighted with the continued progress and reaching this mutually beneficial agreement with AstraZeneca. Following the huge impact of the coronavirus pandemic on society, it's excellent news that we can play our part in the COVID-19 response and help deliver real benefits to the community, through the application of ProAxsis' expertise in respiratory assays."Ruth March, SVP, Precision Medicine, AstraZeneca said: "The development of this serology ELISA by our team is another example of AstraZeneca's comprehensive response to the COVID-19 pandemic. This highly sensitive and specific blood test makes use of simple and convenient fingerstick sample collection that will be well suited to large scale deployment and has the potential to play an important role in antibody analyses in large populations."

[blakieboy7] 07/6/2021 07:29

Licensing agreement with Astrazeneva

[blakieboy7] 07/6/2021 07:29

RNS - London, UK - 7 June 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its wholly owned subsidiary ProAxsis Limited ("ProAxsis" or the Company") has entered into an exclusive licensing agreement with the global biopharmaceutical company AstraZeneca. ProAxsis will take responsibility for completing the validation and global commercialisation of a SARS-CoV-2 (the virus associated with COVID-19) serology ELISA (enzyme-linked immunosorbent assay) developed by an internal research team at AstraZeneca. In return for providing access to the required intellectual property and technical know-how, AstraZeneca will receive a royalty fee on future Global net sales of the assay.Dr. Ilian Iliev, CEO of NetScientific commented: "We are delighted to see continued progress, with another significant step in ProAxsis' expanding product portfolio and market opportunities. The assay could if fully validated potentially attract a substantial market. It is envisaged that the validation and initial commercialisation can be achieved largely from ProAxsis' existing resources."

[kalkaar] 04/6/2021 22:07

Beginning of year:

NSCI: 50p

PDSB: $2.50

[kalkaar] 04/6/2021 20:53

Loaf, would you mind elaborating on the following please:

"I'll walk away with £500K thanks to IG, even though they closed the book weeks ago."

Thanks

[bertiebingo] 04/6/2021 20:34

This may have been posted already, webcast Tues post ASCOhttps://event.webcasts.com/starthere.jsp?ei=1467666&tp_key=7a66e126d4

[bertiebingo] 04/6/2021 20:30

Turn around is exactly why I bought it just before the PDSB frenzy. Simply saw an InvestorMeetCompany invite, read up quickly, liked the idea of a turn around, watched the webinar , bought a small amount then scaled once PDSB moved big and NSCI went down !

[bertiebingo] 04/6/2021 20:27

Yes, in the last few weeks it's been approx 85-103% of NSCI's mkt cap so add back >£5m for non-NSCI which is currently negative

[weatherman] 04/6/2021 20:07

Current value of PDSB at $13.2 is about £12m to NSCI's stake.

[loafofbread] 04/6/2021 19:19

PDSB is going to be a $1 Billion+ company, with or without a takeover.

NSCI stake will be worth £50M and the share price will be 5X todays price at £3.50.

(that's without Glycotest and the Irish company)

I'll walk away with £500K thanks to IG, even though they closed the book weeks ago.

[blakieboy7] 04/6/2021 18:50

Pdsb now up over 13% and over 13 dollars

[bertiebingo] 04/6/2021 18:47

Managed to buy a bit more into the close at 76.5p

[blakieboy7] 04/6/2021 17:20

https://www.proactiveinvestors.co.uk/companies/news/951459/netscientific-refinanced-and-focused-on-enhancing-value-951459.html

[blakieboy7] 04/6/2021 17:18

Pdsb up over 12% so I expect more blue on Monday

[blakieboy7] 04/6/2021 16:29

Nice bit of end of day blue

[kalkaar] 03/6/2021 14:53

and yet the 10-15k selling continues..

[kalkaar] 03/6/2021 12:50

all eyes will be on PDSB stateside come Monday as they will be holding a conference call and will also be presenting their clinical results for PDS101 (Versamune) at ASCO 2021 - more flesh on the bones and confirmation of their findings and it will head much higher and increase the value of NSCI's stake..

positive progress and $20 will seem cheap..

[the stigologist] 03/6/2021 09:35

NAV 200p vs Share Price 75p

No brainer

[stockhunters] 03/6/2021 09:20

new hold probably took remaining Schroders stock

no brainer with NAV double the market cap

[lazygun] 03/6/2021 08:47

New 3% holder.....

[stockhunters] 02/6/2021 17:24

would have been nice if market makers let buyers in at 75p

only allowed sellers